Article Details

ASCO: Entrectinib gets edge over crizotinib against ROS1+ lung cancer

Retrieved on: 2019-05-30 00:52:30

Tags for this article:

Click the tags to see associated articles and topics

ASCO: Entrectinib gets edge over crizotinib against ROS1+ lung cancer. View article details on hiswai:

Excerpt

<div>Combing through tens of thousands of de-identified electronic patient records from <b>Flatiron Health</b>, the authors found 69 patients treated with crizotinib ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up